Skip to main content

Articles

Significant Hospital Costs Tied to 30-Day Readmissions for Allogeneic Transplants

Physicians Must Consider the Financial Burden of Allogeneic Transplants

Clinical Practice Guidelines Should Include Patient’s Preferences

Adverse Events Reporting in Oncology Studies Suboptimal

Ibrutinib Approved for Chronic Lymphocytic Leukemia

Tafinlar Receives Breakthrough Therapy Designation for Lung Cancer

Hematologists Often Ignore Treatment and Monitoring Recommendations

Leukemia, Oncology

Promising Drugs in the Pipeline for Leukemia and Myelodysplastic Syndromes

Decitabine More Cost-Effective than Conventional Induction in Older Patients with AML

New Directions in the Treatment of Multiple Myeloma: Reports on Carfilzomib Therapy from the 2013 Annual Meeting of the American Society of Hematology

Page 160 of 245
Results 1591 - 1600 of 2441